[
  {
    "id": "gen-1764424231-FaVwjuprcrpPOgE395Fh",
    "provider": "Google AI Studio",
    "model": "google/gemini-3-pro-preview",
    "object": "chat.completion",
    "created": 1764424231,
    "choices": [
      {
        "logprobs": null,
        "finish_reason": "stop",
        "native_finish_reason": "STOP",
        "index": 0,
        "message": {
          "role": "assistant",
          "content": "{\n  \"main_diagnosis\": {\n    \"code\": \"I50.1\",\n    \"name\": \"Selhání levé komory\",\n    \"reason\": \"Hlavní příčinou přijetí na ARO a následného úmrtí bylo akutní srdeční selhání s obrazem kardiogenního šoku. Echokardiografické vyšetření potvrdilo selhání levé komory s nízkou ejekční frakcí. Terapeutické úsilí bylo směřováno primárně k podpoře srdečního výdeje (vazopresory, inotropika). Stav je vyhodnocen jako primární orgánové selhání vedoucí k hospitalizaci.\",\n    \"probability\": 95\n  },\n  \"other_potential_main_diagnoses\": [\n    {\n      \"code\": \"R57.0\",\n      \"name\": \"Kardiogenní šok\",\n      \"reason\": \"Dominantní klinický projev při přijetí (hypotenze, nutnost poresorické podpory). Dle pravidel kódování se však upřednostňuje základní onemocnění (I50.1), pokud je známo. Jako HD by bylo použito, pokud by nebylo specifikováno konkrétní srdeční onemocnění.\",\n      \"probability\": 40\n    },\n    {\n      \"code\": \"J69.0\",\n      \"name\": \"Pneumonie způsobená potravou a zvratky\",\n      \"reason\": \"V anamnéze je popsána desaturace bezprostředně po podání Nutridrinku, což naznačuje aspiraci jako spouštěcí moment zhoršení stavu. Byla nasazena antibiotika. Nicméně dominantní obraz a příčina smrti byly kardiální.\",\n      \"probability\": 30\n    }\n  ],\n  \"secondary_diagnoses\": [\n    {\n      \"code\": \"R57.0\",\n      \"name\": \"Kardiogenní šok\",\n      \"reason\": \"Stav vyžadoval agresivní tekutinovou resuscitaci a kombinovanou presorickou podporu (Noradrenalin, Vasopressin). Významně navýšilo náročnost péče.\",\n      \"probability\": 98\n    },\n    {\n      \"code\": \"I48.9\",\n      \"name\": \"Fibrilace síní, neurčená\",\n      \"reason\": \"V textu popsána 'nově vzniklá Fisi', která byla terapeuticky řešena podáním Cordaronu a Digoxinu.\",\n      \"probability\": 95\n    },\n    {\n      \"code\": \"J69.0\",\n      \"name\": \"Pneumonie způsobená potravou a zvratky\",\n      \"reason\": \"Podezření na aspiraci (vazba na krmení a desaturaci), nasazena empirická antibiotická terapie (Amoxicilin/kyselina klavulanová).\",\n      \"probability\": 85\n    },\n    {\n      \"code\": \"N17.9\",\n      \"name\": \"Akutní selhání ledvin, neurčené\",\n      \"reason\": \"Laboratorní známky renální insuficience (Kreatinin 149 umol/l, Urea 18.2 mmol/l, eGFR 0.48 ml/s). Pravděpodobně prerenální etiologie při šoku.\",\n      \"probability\": 90\n    },\n    {\n      \"code\": \"D68.9\",\n      \"name\": \"Porucha srážlivosti, neurčená\",\n      \"reason\": \"Popisována 'spontánní koagulopatie' s INR 3.24 (bez údaje o Warfarinu). Tento stav vedl k rozhodnutí neprovést punkci pleurálního výpotku (vliv na diagnosticko-terapeutický postup).\",\n      \"probability\": 90\n    },\n    {\n      \"code\": \"N39.0\",\n      \"name\": \"Infekce močového ústrojí bez určení lokalizace\",\n      \"reason\": \"Mikrobiologický nález E. coli > 10^5 v moči, leukocyturie, zvýšené PCT (1.13 ug/l). Přestože ATB kryla i toto, nález je signifikantní komplikací.\",\n      \"probability\": 85\n    },\n    {\n      \"code\": \"B96.2\",\n      \"name\": \"Escherichia coli jako příčina nemoci\",\n      \"reason\": \"Identifikované agens u infekce močových cest (kódováno jako doplňkový kód k N39.0).\",\n      \"probability\": 95\n    },\n    {\n      \"code\": \"J96.0\",\n      \"name\": \"Akutní respirační selhání\",\n      \"reason\": \"Vstupní desaturace 85 %, nutnost oxygenoterapie. Hyperoxémie v ASTRUPU následně svědčí o suplementaci kyslíkem.\",\n      \"probability\": 80\n    },\n    {\n      \"code\": \"E87.2\",\n      \"name\": \"Acidóza\",\n      \"reason\": \"Významná laktátová acidóza (Laktát 7.1 mmol/l v prvním odběru), ukazatel tkáňové hypoperfuze.\",\n      \"probability\": 80\n    },\n    {\n      \"code\": \"J90\",\n      \"name\": \"Pleurální výpotek, jinde nezařazený\",\n      \"reason\": \"Diagnostikován na CT (45 mm), zvažována punkce, která byla kontraindikována pro koagulopatii. I pasivní sledování s rozhodovacím procesem opravňuje vykázání.\",\n      \"probability\": 75\n    }\n  ]\n}",
          "refusal": null,
          "reasoning": "**Assessing the Core Data**\n\nI've been drilling down into the clinical data, meticulously parsing it to extract the key diagnostic indicators. My aim is to accurately categorize each piece of information, differentiating between vital data that points to the primary diagnosis and supporting details that could suggest secondary diagnoses. I'm focusing on aligning these findings with ICD-10 and Czech DRG guidelines for a precise output.\n\n\n**Formalizing the Structure**\n\nMy current focus is on structuring the output as a strict, parseable JSON block. I've begun to break down the patient data, assigning specific keys to elements like ID, Dates, and Clinical Picture. I'm carefully translating the complex clinical narrative into a structured format. This will ensure consistency and facilitate further analysis of the data by systems.\n\n\n**Identifying Key Diagnoses**\n\nI'm now zeroing in on the principal diagnosis and potential secondary conditions. The data strongly points towards Heart Failure as the primary cause, backed by clear clinical evidence of left ventricular failure, low ejection fraction, and cardiogenic shock. I'm also considering Aspiration Pneumonia, given the \"suspected aspiration\" and antibiotic treatment. Although the urine analysis indicates a possible UTI, the cardiogenic shock seems more prominent, but this data will influence the differential diagnoses.\n\n\n**Determining Primary Code**\n\nMy focus is now firmly on the primary diagnosis code. While initially considering Pulmonary Embolism due to the elevated D-Dimer, the ECHO findings of left ventricular failure have steered me towards a heart failure diagnosis. I'm choosing between I50.1 (left ventricular failure) and I50.9 (heart failure, unspecified), considering the cardiogenic shock. DRG guidelines suggest prioritizing the underlying cause. While cardiogenic shock (R57.0) is a crucial symptom, the heart failure necessitated the admission and treatment, so it fits as the primary diagnosis.\n\n\n**Identifying Secondary Codes**\n\nI've completed the primary diagnosis and am now determining the secondary codes. The patient's presentation included cardiogenic shock, which I've selected as R57.0. Atrial fibrillation, treated with Cordarone and Digoxin, will be coded as I48.9. I've also identified a urinary tract infection, confirmed by the urine findings of E. coli and elevated PCT, which I'll categorize as N39.0.\n\n\n**Detailing Secondary Conditions**\n\nI'm now diving into the secondary codes to encapsulate all relevant aspects of the case. I've pinpointed several key conditions: J69.0 (Aspiration pneumonia), due to the suspected aspiration and empirical antibiotic treatment, which has to be coded in DRG. R40.0 (Somnolence) or R40.1, linked with the patient's consciousness state, will be included. N17.9 (Acute kidney injury) is supported by the creatinine and urea levels and GFR. I'm also considering a bleeding disorder, coded as D68.9 based on the INR of 3.24. Finally, I'll assess J90 (Pleural effusion), considering the specifics mentioned.\n\n\n**Expanding the Diagnosis List**\n\nMy work now involves adding further precision to the secondary diagnoses. I'm focusing on the respiratory and metabolic imbalances, specifically coding for the acute respiratory failure, hypoxemia, and lactic acidosis, all contributing to the patient's deteriorating condition. E. coli will be coded to specify the causative agent of the UTI.\n\n\n**Adding Detailed Symptoms**\n\nI'm now integrating the additional symptoms and complications observed. Given the information available, I'm leaning towards including I46.9 (Cardiac arrest). This code fits the critical turn of events described, and it's essential for a comprehensive diagnostic perspective. I'm carefully considering how to represent the patient's condition for the best clinical picture.\n\n```json\n[\n  {\n    \"code\": \"R57.0\",\n    \"name\": \"Cardiogenic shock\",\n    \"notes\": \"Essential. Treated with vasoactive drugs.\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"I48.9\",\n    \"name\": \"Atrial Fibrillation\",\n    \"notes\": \"New onset.\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"J69.0\",\n    \"name\": \"Pneumonitis due to food/solid\",\n    \"notes\": \"Suspected aspiration\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"N17.9\",\n    \"name\": \"Acute renal failure\",\n    \"notes\": \"Creatinine 149, Urea high\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"N39.0\",\n    \"name\": \"UTI\",\n    \"notes\": \"Micro finding + increased PCT/CRP\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"B96.2\",\n    \"name\": \"E. Coli\",\n    \"notes\": \"Causative agent for UTI.\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"D68.9\",\n    \"name\": \"Coagulation defect\",\n    \"notes\": \"INR 3.24, prevented procedure.\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"I46.9\",\n    \"name\": \"Cardiac arrest\",\n    \"notes\": \"Key code for patient outcome.\",\n    \"type\": \"final diagnosis\"\n  },\n  {\n    \"code\": \"J90\",\n    \"name\": \"Pleural effusion\",\n    \"notes\": \"\",\n    \"type\": \"complication\"\n  }\n]\n```\n\n\n**Finalizing Code Assignment**\n\nI'm now fully immersed in the final coding stages, having addressed several critical elements. I've thoroughly considered the ICD-10 codes, prioritizing those that best reflect the clinical scenario. Specifically, I've integrated J96.0 for acute respiratory failure, E87.2 for acidosis and am in the process of finalizing the structure. I'm taking the opportunity to re-check all the information, for the main I50.1 code and the rest of the VDs, to avoid any omissions or redundancies.\n\n\n**Confirming the Principal Diagnosis**\n\nI've been closely analyzing the clinical trajectory, specifically the desaturation episode following Nutridrink. While J69.0 (Aspiration pneumonia) seems significant, the patient's three-day deterioration and the hemodynamic focus of the treatment suggest I50.1 (Left ventricular failure) as the primary driver. I'm carefully considering the impact of the aspiration event within the broader context of the heart failure picture, especially the aggressive treatment of the failure, over the course of three days, and the need for pressors.\n\n\n**Generating Czech Output**\n\nI'm now translating the findings into a Czech-language JSON output.  I'm focusing on accurately representing the diagnoses with their corresponding ICD-10 codes, like I50.1 for heart failure, and the secondary conditions like R57.0 for cardiogenic shock and I48.9 for atrial fibrillation.  I'm also considering the appropriate Czech terminology.\n\n\n**Prioritizing Czech Codes**\n\nNow I'm focusing on translating the code descriptions, ensuring they are accurately rendered in Czech, including *Pneumonie způsobená potravou a zvratky* for J69.0, *Akutní selhání ledvin* for N17.9, and *Porucha srážlivosti* for D68.9. I'm also carefully incorporating probability assessments for clinical reasoning, refining the output to reflect the nuances of the case, and generating the final output.\n\n\n\n**Reviewing Final Adjustments**\n\nI'm now putting the finishing touches on the Czech JSON output. I'm double-checking the code assignments, like I50.1 for heart failure, and the secondary conditions like R57.0 for cardiogenic shock and I48.9 for atrial fibrillation. I've ensured all codes are accurately translated, including the probability assessment. My current focus is validating the syntax and ensuring the output meets the highest accuracy. I'm focusing on the additional considerations provided by the data.\n\n\n",
          "reasoning_details": [
            {
              "format": "google-gemini-v1",
              "index": 0,
              "type": "reasoning.text",
              "text": "**Assessing the Core Data**\n\nI've been drilling down into the clinical data, meticulously parsing it to extract the key diagnostic indicators. My aim is to accurately categorize each piece of information, differentiating between vital data that points to the primary diagnosis and supporting details that could suggest secondary diagnoses. I'm focusing on aligning these findings with ICD-10 and Czech DRG guidelines for a precise output.\n\n\n**Formalizing the Structure**\n\nMy current focus is on structuring the output as a strict, parseable JSON block. I've begun to break down the patient data, assigning specific keys to elements like ID, Dates, and Clinical Picture. I'm carefully translating the complex clinical narrative into a structured format. This will ensure consistency and facilitate further analysis of the data by systems.\n\n\n**Identifying Key Diagnoses**\n\nI'm now zeroing in on the principal diagnosis and potential secondary conditions. The data strongly points towards Heart Failure as the primary cause, backed by clear clinical evidence of left ventricular failure, low ejection fraction, and cardiogenic shock. I'm also considering Aspiration Pneumonia, given the \"suspected aspiration\" and antibiotic treatment. Although the urine analysis indicates a possible UTI, the cardiogenic shock seems more prominent, but this data will influence the differential diagnoses.\n\n\n**Determining Primary Code**\n\nMy focus is now firmly on the primary diagnosis code. While initially considering Pulmonary Embolism due to the elevated D-Dimer, the ECHO findings of left ventricular failure have steered me towards a heart failure diagnosis. I'm choosing between I50.1 (left ventricular failure) and I50.9 (heart failure, unspecified), considering the cardiogenic shock. DRG guidelines suggest prioritizing the underlying cause. While cardiogenic shock (R57.0) is a crucial symptom, the heart failure necessitated the admission and treatment, so it fits as the primary diagnosis.\n\n\n**Identifying Secondary Codes**\n\nI've completed the primary diagnosis and am now determining the secondary codes. The patient's presentation included cardiogenic shock, which I've selected as R57.0. Atrial fibrillation, treated with Cordarone and Digoxin, will be coded as I48.9. I've also identified a urinary tract infection, confirmed by the urine findings of E. coli and elevated PCT, which I'll categorize as N39.0.\n\n\n**Detailing Secondary Conditions**\n\nI'm now diving into the secondary codes to encapsulate all relevant aspects of the case. I've pinpointed several key conditions: J69.0 (Aspiration pneumonia), due to the suspected aspiration and empirical antibiotic treatment, which has to be coded in DRG. R40.0 (Somnolence) or R40.1, linked with the patient's consciousness state, will be included. N17.9 (Acute kidney injury) is supported by the creatinine and urea levels and GFR. I'm also considering a bleeding disorder, coded as D68.9 based on the INR of 3.24. Finally, I'll assess J90 (Pleural effusion), considering the specifics mentioned.\n\n\n**Expanding the Diagnosis List**\n\nMy work now involves adding further precision to the secondary diagnoses. I'm focusing on the respiratory and metabolic imbalances, specifically coding for the acute respiratory failure, hypoxemia, and lactic acidosis, all contributing to the patient's deteriorating condition. E. coli will be coded to specify the causative agent of the UTI.\n\n\n**Adding Detailed Symptoms**\n\nI'm now integrating the additional symptoms and complications observed. Given the information available, I'm leaning towards including I46.9 (Cardiac arrest). This code fits the critical turn of events described, and it's essential for a comprehensive diagnostic perspective. I'm carefully considering how to represent the patient's condition for the best clinical picture.\n\n```json\n[\n  {\n    \"code\": \"R57.0\",\n    \"name\": \"Cardiogenic shock\",\n    \"notes\": \"Essential. Treated with vasoactive drugs.\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"I48.9\",\n    \"name\": \"Atrial Fibrillation\",\n    \"notes\": \"New onset.\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"J69.0\",\n    \"name\": \"Pneumonitis due to food/solid\",\n    \"notes\": \"Suspected aspiration\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"N17.9\",\n    \"name\": \"Acute renal failure\",\n    \"notes\": \"Creatinine 149, Urea high\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"N39.0\",\n    \"name\": \"UTI\",\n    \"notes\": \"Micro finding + increased PCT/CRP\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"B96.2\",\n    \"name\": \"E. Coli\",\n    \"notes\": \"Causative agent for UTI.\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"D68.9\",\n    \"name\": \"Coagulation defect\",\n    \"notes\": \"INR 3.24, prevented procedure.\",\n    \"type\": \"complication\"\n  },\n  {\n    \"code\": \"I46.9\",\n    \"name\": \"Cardiac arrest\",\n    \"notes\": \"Key code for patient outcome.\",\n    \"type\": \"final diagnosis\"\n  },\n  {\n    \"code\": \"J90\",\n    \"name\": \"Pleural effusion\",\n    \"notes\": \"\",\n    \"type\": \"complication\"\n  }\n]\n```\n\n\n**Finalizing Code Assignment**\n\nI'm now fully immersed in the final coding stages, having addressed several critical elements. I've thoroughly considered the ICD-10 codes, prioritizing those that best reflect the clinical scenario. Specifically, I've integrated J96.0 for acute respiratory failure, E87.2 for acidosis and am in the process of finalizing the structure. I'm taking the opportunity to re-check all the information, for the main I50.1 code and the rest of the VDs, to avoid any omissions or redundancies.\n\n\n**Confirming the Principal Diagnosis**\n\nI've been closely analyzing the clinical trajectory, specifically the desaturation episode following Nutridrink. While J69.0 (Aspiration pneumonia) seems significant, the patient's three-day deterioration and the hemodynamic focus of the treatment suggest I50.1 (Left ventricular failure) as the primary driver. I'm carefully considering the impact of the aspiration event within the broader context of the heart failure picture, especially the aggressive treatment of the failure, over the course of three days, and the need for pressors.\n\n\n**Generating Czech Output**\n\nI'm now translating the findings into a Czech-language JSON output.  I'm focusing on accurately representing the diagnoses with their corresponding ICD-10 codes, like I50.1 for heart failure, and the secondary conditions like R57.0 for cardiogenic shock and I48.9 for atrial fibrillation.  I'm also considering the appropriate Czech terminology.\n\n\n**Prioritizing Czech Codes**\n\nNow I'm focusing on translating the code descriptions, ensuring they are accurately rendered in Czech, including *Pneumonie způsobená potravou a zvratky* for J69.0, *Akutní selhání ledvin* for N17.9, and *Porucha srážlivosti* for D68.9. I'm also carefully incorporating probability assessments for clinical reasoning, refining the output to reflect the nuances of the case, and generating the final output.\n\n\n\n**Reviewing Final Adjustments**\n\nI'm now putting the finishing touches on the Czech JSON output. I'm double-checking the code assignments, like I50.1 for heart failure, and the secondary conditions like R57.0 for cardiogenic shock and I48.9 for atrial fibrillation. I've ensured all codes are accurately translated, including the probability assessment. My current focus is validating the syntax and ensuring the output meets the highest accuracy. I'm focusing on the additional considerations provided by the data.\n\n\n"
            },
            {
              "format": "google-gemini-v1",
              "index": 0,
              "type": "reasoning.encrypted",
              "data": "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"
            }
          ]
        }
      }
    ],
    "usage": {
      "prompt_tokens": 5051,
      "completion_tokens": 5100,
      "total_tokens": 10151,
      "prompt_tokens_details": {
        "cached_tokens": 0
      },
      "completion_tokens_details": {
        "reasoning_tokens": 3729,
        "image_tokens": 0
      }
    },
    "_patient_id": "1"
  }
]